ArticleCell cycle (Georgetown, Tex.)2020

LncRNA TSLNC8 synergizes with EGFR inhibitor osimertinib to inhibit lung cancer tumorigenesis by blocking the EGFR-STAT3 pathway.

Su-Zhen Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.